http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03284624-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1990-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0468f8ba62196669f313b99719380167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1b76eaab057235052cb95092d5d6ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_344e498f17fc0be6be1732b97c240aaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c55a3439472ed8e6e52ca70c8ad6bf68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8dc54e14add66dda637945f99d3229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a68bf6a428e2db78c87d0de3ea0468
publicationDate 1991-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03284624-A
titleOfInvention Antiviral agent
abstract PURPOSE: To obtain an antiviral agent effective against AIDS virus, etc., having activity against retrovirus and low toxicity, comprising 5 ethyl-1-[(2- hydroxyethoxy)methyl]-6-phenylthiouracil, etc., as an active ingredient. n CONSTITUTION: An antiviral agent comprising 5-ethyl-1-[(2-hydroxyethoxy) methyl]-6-phenylthiouracil shown by formula I or 1-[(2-hydroxyethoxy)methyl]-6- phenylthio-5-isopropyluracil shown by formula II as an active ingredient. The compound can be administered for prevention and treatment of infection with retrovirus, etc., by any route such as oral administration, administration per rectum, parenteral administration or local administration. A daily dose is selected from a range of 1-100mg/kg weight, preferably 5-50mg/kg weight and administered once or more times. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526846-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935710-B2
priorityDate 1990-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234236225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415969692
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57226588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67684383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234236777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423570938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234236787
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID31931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88511321
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235127171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67922258
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID31931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234236362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235127168

Total number of triples: 42.